US Drugs of Abuse Testing Market
This unique report from provides information and analysis not available from any other published source.
The report is available by section, and can be customized to specific information needs and budget.
This new report from provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Mindray
- Quest Diagnostics
- QuidelOrtho
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
Market and Technology Overview
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
List Of Tables
Major Companies Developing or MarketingDrugs of Abuse Tests
U.S.A., Drugs of Abuse Test Volume
Forecast By Market Segment
U.S.A., All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., Drugs of Abuse Reagent Market
Forecast By Market Segment by Assay
U.S.A., All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
2024 US Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 US Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 567 pages
USD 3450 View Report2024 US Hospital Microbiology Analyzers and Consumables Tests Supplier Shares and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 US Hospital Microbiology Analyzers and Consumables for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains
USD 3450 View Report2024 US Drugs Abuse Testing Market Assays Supplier Shares
2024 US Drugs of Abuse Testing Market for 12 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new 262-page
USD 2850 View Report2024 U.S. Drugs of Abuse POC Decentralized Testing Market
2024 U.S. Drugs of Abuse POC/Decentralized Testing Market: Country Supplier Shares, Test Volume and Sales Segment ForecastsThis new 165-page report from contains 14 tables, and provides a comprehensive analysis
USD 2500 View ReportFill The Form For Sample Request